Popular on s4story
- Rock Island Prison 1864 - An Award Winning Drama Sheds Light on the Untold Story of Black Union Soldiers
- Post-Oscar Iftar Night Celebrates Academy Award-Winning Documentary No Other Land with a Packed House
- Behind A Pyramid Lake Story: An Exclusive Interview with the Award-Winning Author
- $15 Million in New Equity to Support Advanced Cancer Diagnostics, Personalized Immunotherapy, Treatments & Drug Discovery: Renovaro Stock Symbol: RENB
- From Despair to Design: Renowned Jewelry Designer, Danielle Nicole Enright Seeks Her Pay It Forward Angel
- Coker Completes Acquisition of Leading Healthcare Advisory Firm, Health Care Program Advisors
- Best-Selling Author Maurice I. Crawford Unveils Explosive New Book
- No, Mom and Dad, I Won't Let You Kill Me!" – Groundbreaking Memoir Tops Amazon's New Releases
- For Saving Home Services Inc. Helps GTA Homeowners Save with Heat Pump Rebates
Similar on s4story
- NaturismRE Calls for Body Acceptance Education in Schools to Tackle Youth Mental Health & Physical Inactivity
- Dentaluxe's New Website Launch!
- Matt Stuckert Joins Lineus Medical Board of Directors
- Fray Fitness Launches Redesigned Website to Enhance Customer Experience
- Brookline Family Dentistry Updates Website URL for a Stronger Brand Identity
- $300 Million in Milestones Plus Tiered Double-Digit Royalties to License & Distribute NRX-100 Drug: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- Mental Health Watchdog Seeks Action Amid Alarming Patient Sexual Abuse Cases
- Arthur Murray Dance Studio Modena: Discover the Joy of Dance
- STRETCHIT Announces it is Now Available to Millions of Employees on Wellhub, the Leader in Corporate Wellness
- Sip, Savor, and Celebrate Earth Day on the Shawangunk Wine Trail - April 26-27, 2025
Dr. Jeff Gelblum Provides Alzheimer's Treatment to Patients in the US and Abroad
S For Story/10632349
AVENTURA, Fla. - s4story -- Dr. Jeff Gelblum, Neurologist at First Choice Neurology, has brought together clinical, imaging, and laboratory capabilities to provide rapid diagnosis and treatment to individuals suffering from Alzheimer's disease.
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on S For Story
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on S For Story
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on S For Story
- In-Depth Analysis of Amazon's 2024 Book Sales Data, Revealing Key Genre Trends and Bestselling Insights
- Etan Polinger Officially Recognized As New Mexico's First Certified Ai Consultant
- Expert Law Attorneys Nominates 2025 Personal Injury Firms
- The Ripple Effect Arts Leverages Social Media to Showcase the Benefits of Magic Magnesium Spray, Driving 200% Audience Growth
- Meet the Author: Bev Jennings, CEO of SEE Company, for an Exclusive Book Signing & Author Talk at St. John Knits in St. Augustine
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on S For Story
- America Is Being Ripped Off: It's Time To Take Action Against Fraud & Foreign Exploitation
- RESEARCH: Creative People are Healthier, Wealthier, and Live Longer
- Independence Title Honored for Excellence in Fraud Prevention by Stewart Title
- Dentaluxe's New Website Launch!
- PawTides.com Partners with Rescue 22 Foundation to Support Veterans and Rescue Dogs
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
Source: First Choice Neurology
0 Comments
Latest on S For Story
- Jose Silva's Guide to Effective Decision Making and Goal Setting
- Fray Fitness Launches Redesigned Website to Enhance Customer Experience
- Rampage Jackson and Rashad Evans Face Off At Press Conference At The Palms Casino Resort in Las Vegas on March 20, 2025
- Wordeee Releases "Doctor to Patient: Living with Stiff Person Syndrome" by Dr. Tracy Scott
- New Memoir Many Lives, One Soul Chronicles a Journey of Survival, Redemption, and Self-Discovery
- Drone Light Shows Become the Must-Have Entertainment Trend for Events and Venues
- Multi-Million Dollar Contracts and Key Partnerships for Cybersecurity Solutions in the Rapidly Growing Market Nearing $200 Billion Annually $CYCU
- Unveil Hydrogen-Powered Maritime Innovation at H2Hub Summit
- Brookline Family Dentistry Updates Website URL for a Stronger Brand Identity
- Grassy Waters Conservancy Reveals the Secret of the Everglades in SAM THE SNAIL KITE
- New Book by Dana McIntyre Introduces Boomers to Cryptocurrency
- Major Defense Contractor, Satellite and Multiple Deployable Tech Companies Partnering with Ascent Solar Technologies, Inc: Stock Symbol: ASTI
- Rosann Santos Ofrece el Programa Repensando el Síndrome del Impostor™
- Criptlán Partners with Top Capital and Technology Teams to Drive the Future of the Digital Economy
- From Sea to the Site: The Evolution of the Shipping Container From the Water to the Worksite
- History Matters: Book Recommendations for March
- Inbound Lead Generation for Security Companies in 2025: The Key to Sustainable Growth
- Frame Up Now Leverages Cyntexa and Salesforce to Fuel Their Operations & Power Up Lead Conversion
- M Film Lab Launches Spring 2025 Screenwriting Lab: Tales of Identity & Imagination